Article
249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.
BMC cancer - 26 Jun 2009
Nogueira Jeronimo A, Ono-Nita Suzane K, Nita Marcelo E, de Souza Marcelo M T, do Carmo Eliane P, Mello Evandro S, Scapulatempo Cristovan, Paranaguá-Vezozzo Denise C, Carrilho Flair J, Alves Venancio A F
Abstract excerpt
BACKGROUND: Ser-249 TP53 mutation (249(Ser)) is a molecular evidence for aflatoxin-related carcinogenesis in Hepatocellular Carcinoma (HCC) and it is frequent in some African and Asian regions, but it is unusual in Western countries. HBV has been claimed to add a synergic effect on genesis of this particular mutation with aflatoxin. The aim of this study was to investigate the frequency of 249(Ser) mutation in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
